Things have been going well for Biosensors International. It recently announced another good set of results for the second quarter ended September 30, 2011. Revenue for the quarter increased 71% due to higher product, licensing and royalties revenue. This helped drive earnings to USD 23 million.
The company announced that it had completed the proposed acquisition of the remaining 50% in JW Medical Systems. This has been an extremely protracted process due to the regulatory approvals needed and with its completion, will allow Biosensors an effective channel into the Chinese market.
Its share price has responded positively to both consistent earnings growth and corporate developments, gaining more than 20% on a year-to-date basis.